4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-22-072369
Chief Financial Officer bought 12,000 shares at $1.27 ($15,240)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fitzgerald Thomas A Chief Financial Officer | 2022-06-16 | Purchase | +12,000 | $1.27 | $15,240 | 139,377 | D |
| Open-market purchases · 12,000 sh · avg $1.27 · $15,240 | |||||||
Loading xslF345X03/tm2218778-1_4seq1.xml…